5 Key Topics of CVDTx 2020:
Covid-19 Impact on DTx Exploring the implications of FDA guidance to ease restrictions on digital tools for mental health disorders during Covid-19 and showcasing insight into how DTx will continue to grow during and after the pandemic.
Overcoming the Reimbursement Conundrum Gaining first-hand insight from a payer on how to unlock health and economic outcomes for DTx at scale
Evidence Generation, Clinical Trials & Patient-Centric Development Understanding the value of patientcentricity by hearing the patient perspective and learn how to put the patient first
Regulatory Guidelines Breaking down misconceptions, exploring different routes to market and hearing alternative models used in other markets
Becoming Mainstream – Scalability & Commercial Factors to Drive Adoption Optimizing scalability and sustainability strategies to break through the market and ensure commercial success